Literature DB >> 16153703

CDKs promote DNA replication origin licensing in human cells by protecting Cdc6 from APC/C-dependent proteolysis.

Niels Mailand1, John F X Diffley.   

Abstract

Cyclin-dependent kinases (CDKs) restrict DNA replication origin firing to once per cell cycle by preventing the assembly of prereplicative complexes (pre-RCs; licensing) outside of G1 phase. Paradoxically, under certain circumstances, CDKs such as cyclin E-cdk2 are also required to promote licensing. Here, we show that CDK phosphorylation of the essential licensing factor Cdc6 stabilizes it by preventing its association with the anaphase promoting complex/cyclosome (APC/C). APC/C-dependent Cdc6 proteolysis prevents pre-RC assembly in quiescent cells and, when cells reenter the cell cycle from quiescence, CDK-dependent Cdc6 stabilization allows Cdc6 to accumulate before the licensing inhibitors geminin and cyclin A which are also APC/C substrates. This novel mechanism for regulating protein stability establishes a window of time prior to S phase when pre-RCs can assemble which we propose represents a critical function of cyclin E.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16153703     DOI: 10.1016/j.cell.2005.08.013

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  161 in total

Review 1.  Insights into phosphorylation-dependent mechanisms regulating USP1 protein stability during the cell cycle.

Authors:  Xiomaris M Cotto-Rios; Mathew J K Jones; Tony T Huang
Journal:  Cell Cycle       Date:  2011-12-01       Impact factor: 4.534

2.  HBx protein of hepatitis B virus promotes reinitiation of DNA replication by regulating expression and intracellular stability of replication licensing factor CDC6.

Authors:  Vijaya Pandey; Vijay Kumar
Journal:  J Biol Chem       Date:  2012-04-19       Impact factor: 5.157

3.  Chromatin remodeler sucrose nonfermenting 2 homolog (SNF2H) is recruited onto DNA replication origins through interaction with Cdc10 protein-dependent transcript 1 (Cdt1) and promotes pre-replication complex formation.

Authors:  Nozomi Sugimoto; Takashi Yugawa; Masayoshi Iizuka; Tohru Kiyono; Masatoshi Fujita
Journal:  J Biol Chem       Date:  2011-09-20       Impact factor: 5.157

4.  Reducing MCM levels in human primary T cells during the G(0)-->G(1) transition causes genomic instability during the first cell cycle.

Authors:  S J Orr; T Gaymes; D Ladon; C Chronis; B Czepulkowski; R Wang; G J Mufti; E M Marcotte; N S B Thomas
Journal:  Oncogene       Date:  2010-05-03       Impact factor: 9.867

5.  New roles for cyclin E in megakaryocytic polyploidization.

Authors:  Alexia Eliades; Nikolaos Papadantonakis; Katya Ravid
Journal:  J Biol Chem       Date:  2010-04-14       Impact factor: 5.157

Review 6.  Substrate-specific regulation of ubiquitination by the anaphase-promoting complex.

Authors:  Ling Song; Michael Rape
Journal:  Cell Cycle       Date:  2011-01-01       Impact factor: 4.534

7.  Feedback regulation between atypical E2Fs and APC/CCdh1 coordinates cell cycle progression.

Authors:  Michiel Boekhout; Ruixue Yuan; Annelotte P Wondergem; Hendrika A Segeren; Elsbeth A van Liere; Nesibu Awol; Imke Jansen; Rob M F Wolthuis; Alain de Bruin; Bart Westendorp
Journal:  EMBO Rep       Date:  2016-02-05       Impact factor: 8.807

8.  The functional role of Cdc6 in S-G2/M in mammalian cells.

Authors:  Eric Lau; Changjun Zhu; Robert T Abraham; Wei Jiang
Journal:  EMBO Rep       Date:  2006-01-27       Impact factor: 8.807

9.  Nucleocytoplasmic shuttling of bovine papillomavirus E1 helicase downregulates viral DNA replication in S phase.

Authors:  Chiung-Yueh Hsu; Francisca Mechali; Catherine Bonne-Andrea
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

10.  Regulatory evolution in proteins by turnover and lineage-specific changes of cyclin-dependent kinase consensus sites.

Authors:  Alan M Moses; Muluye E Liku; Joachim J Li; Richard Durbin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.